Market Closed -
Other stock markets
|
After market 15:59:30 | |||
154.6 EUR | +0.36% |
|
154.6 | +0.02% |
10:05pm | MERCK KGAA : Receives a Buy rating from Jefferies | ZD |
07-10 | Merck KGaA: share price down, analyst lowers target | CF |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.25% | 72.87B | |
+34.09% | 10.31B | |
+40.41% | 5.23B | |
-15.24% | 4.62B | |
+11.62% | 3.52B | |
+26.25% | 2.31B | |
-38.78% | 1.78B | |
-44.54% | 1.69B | |
-0.50% | 1.64B | |
+0.03% | 1.59B |
- Stock Market
- Equities
- MRK Stock
- News Merck KGaA
- Merck KGaA's Bladder Cancer Drug Shown to Extend Patients' Lives in Real-world Studies